- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Medicamen Organics held an analysts' and investors' meeting via Zoom, engaging with several institutions and individuals to discuss the company's current status and future outlook. The meeting format was Q&A, allowing participants to clarify their inquiries directly with the company representatives. Notably, no new sensitive information was disclosed, indicating a focused environment on existing operations and strategies. This interaction serves as an opportunity for the market to gauge investor sentiment and management’s responses to pertinent queries without the introduction of unpublished price-sensitive information. Overall, the company appears poised to maintain transparency and engagement with its investor base.